chemopred

chemopred predicts chemokines and chemokine receptors and classifies them into subfamilies and families using a support vector machine (SVM) approach to support research on chemokine-receptor function.

Key Features:

• SVM-based prediction: Uses a support vector machine (SVM) methodology to identify chemokines and chemokine receptors.
• Prediction accuracy: Reports 95.08% accuracy for chemokines and 92.19% accuracy for chemokine receptors.
• Subfamily and family classification: Classifies chemokines into three subfamilies with 96.00% overall accuracy and chemokine receptors into three families with 92.87% accuracy.
• GPCR targets: Targets seven-pass transmembrane G-protein-coupled chemokine receptors as prediction targets.
• Biological roles retained: References chemokine functions including leukocyte trafficking, T cell differentiation, angiogenesis, hematopoiesis, mast cell degranulation, HIV-1 inhibition, and roles in antitumor immunotherapy.
• Relevance to virology and drug discovery: Notes chemokine receptors act as HIV-1 co-receptors and are relevant targets for small-molecule development.

Scientific Applications:

• Immunology studies: Support analysis of chemokine-mediated processes such as leukocyte trafficking, T cell differentiation, angiogenesis, hematopoiesis, and mast cell degranulation.
• HIV research: Enable investigation of chemokines as HIV-1 inhibitors and chemokine receptors as HIV-1 co-receptors for viral entry.
• Antitumor immunotherapy: Facilitate study of chemokines as natural adjuvants in antitumor immunotherapy.
• Pharmaceutical development: Inform small-molecule development targeting chemokine GPCRs.

Methodology:

Prediction and classification are performed using a support vector machine (SVM)-based method.